Reglicem: a clinically validated food supplement supports the control type 2 diabetes epidemy
February 2023
Reglicem is an innovative nutraceutical product developed by Biofarma Group, able to reduce IFG and IGT values in patients with prediabetes conditions.
- Curcuma longa is effective in reducing glycemia and hyperlipidaemia and improves insulin sensitivity
- Berberis vulgaris promotes glucose and HbA1c lowering in patients with diabetes type II
- Lagerstroemia speciosa exhibits hypoglycaemic, antihyperlipidemic and antioxidant activities.
- Inositol is effective in decreasing the level of insulin resistance
- Chromium acts as an ‘insulin-sensitizing’ agent
This Techincal Paper is from Biofarma.
